跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRINEURA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BRINEURA
Authorized
STANDARD
BRINEURA
Biomarin International Limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b3fcd7f18640bde8
Company
Biomarin International Limited
Type
Standard
Approval Details
Approval Id
b3fcd7f18640bde8
Drug Approval Canada Name
BRINEURA
Product Name
BRINEURA
Status
Marketed
Status Date
2019-03-18
Original Market Date
2019-03-18
Din
02484013
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intracerebroventricular
Schedule
Prescription , Schedule D
Ahfs
44:00.00
Atc Original
A16AB17 CERLIPONASE ALFA
Atc Name
a 16 ab 17
Aig Number
0161050001
Company Name
Biomarin International Limited
Company Address
Shanbally, Ringaskiddy, Cork, Ireland, P43R298
Company Detail Path
/organization/biomarin-international-limited
Company Information
Pharmaceutical Company Name
Biomarin International Limited
Country Name
Australia
Active Ingredients
CERLIPONASE ALFA
150 MG / 5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b3fcd7f18640bde8
Type
Standard
Back to Health Canada Approvals